Complete Filing Data
Lyra Therapeutics, Inc. reported Stockholders Equity of -$10.72 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lyra Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$28.9M | -$93.4M | -$62.7M | -$55.3M | -$43.5M | -$22.1M | -$16.3M |
| Research And Development Expense | $18.4M | $43.8M | $48.0M | $38.8M | $29.7M | $12.5M | $12.0M |
| Operating Income Loss | -$31.0M | -$96.3M | -$67.1M | -$56.3M | -$43.6M | -$22.2M | -$16.5M |
| Operating Expenses | $31.4M | $97.9M | $68.7M | $57.7M | $43.9M | $22.2M | $16.5M |
| Nonoperating Income Expense | $2.1M | $3.0M | $4.5M | $1.0M | $102.0K | $82.0K | $213.0K |
| General And Administrative Expense | $11.5M | $18.5M | $19.1M | $17.6M | $14.2M | $9.7M | $4.5M |
| Comprehensive Income Net Of Tax | -$28.9M | -$93.5M | -$62.7M | -$55.3M | -$43.5M | -$22.1M | -$16.3M |
| Revenue From Contract With Customer Excluding Assessed Tax | $398.0K | $1.5M | $1.6M | $1.4M | $285.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$28.9M | -$93.4M | -$62.6M | -$55.3M | -$43.5M | ||
| Deferred Revenue Noncurrent | $11.9M | $11.9M | $12.1M | $14.1M | $1.9M | ||
| Deferred Revenue Current | $398.0K | $1.7M | $1.3M | $9.8M | |||
| Income Tax Expense Benefit | $11.0K | $39.0K | $59.0K | $13.0K | |||
| Impairment Of Long Lived Assets To Be Disposed Of | $1.9M | $1.6M | $1.3M | $0.00 | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$33.0K | $23.0K | $10.0K | ||||
| Restructuring Charges | $1.5M | $10.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.0M | -$7.4M | -$8.5M | -$11.9M | -$48.1M | -$22.5M | -$15.7M | -$15.6M | -$16.3M | -$14.8M | -$14.4M | -$11.9M | -$11.1M | -$11.0M | -$7.8M | -$6.3M | -$4.5M | -$4.2M | -$4.2M | -$4.2M | -$3.6M |
| Research And Development Expense | $4.0M | $5.1M | $4.9M | $5.9M | $13.3M | $18.2M | $12.4M | $10.8M | $12.6M | $10.0M | $10.8M | $8.5M | $7.1M | $7.5M | $4.8M | $3.7M | $2.1M | $3.0M | $2.8M | $3.4M | $2.8M |
| Operating Income Loss | -$6.2M | -$8.8M | -$8.8M | -$12.4M | -$49.0M | -$23.5M | -$16.8M | -$16.5M | -$17.3M | -$14.8M | -$14.4M | -$11.9M | -$11.1M | -$11.1M | -$7.8M | -$6.4M | -$4.5M | -$4.2M | -$4.2M | -$4.3M | -$3.6M |
| Operating Expenses | $6.3M | $9.0M | $9.0M | $12.6M | $49.6M | $24.1M | $17.4M | $17.0M | $17.7M | $15.2M | $14.9M | $12.4M | $11.1M | $11.1M | $7.8M | $6.4M | $4.5M | $4.2M | $4.2M | $4.3M | $3.6M |
| Nonoperating Income Expense | $256.0K | $1.4M | $298.0K | $576.0K | $855.0K | $1.1M | $1.2M | $897.0K | $1.1M | $60.0K | $34.0K | $14.0K | $26.0K | $26.0K | $29.0K | $29.0K | $5.0K | $16.0K | $63.0K | $80.0K | $35.0K |
| General And Administrative Expense | $2.2M | $3.5M | $3.3M | $3.9M | $5.1M | $5.8M | $5.0M | $4.6M | $5.1M | $5.1M | $4.1M | $3.9M | $4.0M | $3.6M | $3.1M | $2.7M | $2.4M | $1.3M | $1.4M | $865.0K | $860.0K |
| Comprehensive Income Net Of Tax | -$6.0M | -$7.4M | -$8.5M | -$11.8M | -$48.2M | -$22.5M | -$15.6M | -$15.6M | -$16.3M | -$14.8M | -$14.4M | -$11.9M | -$11.1M | -$11.0M | -$7.8M | -$6.3M | -$4.5M | -$4.2M | -$4.2M | -$4.2M | -$3.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $25.0K | $183.0K | $183.0K | $195.0K | $598.0K | $532.0K | $544.0K | $458.0K | $410.0K | $359.0K | $525.0K | $468.0K | $14.0K | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.0M | -$7.4M | -$8.5M | -$11.9M | -$48.1M | -$22.4M | -$15.6M | -$15.6M | -$16.2M | -$14.8M | -$14.4M | -$11.9M | |||||||||
| Deferred Revenue Noncurrent | $11.9M | $11.9M | $11.9M | $11.9M | $11.9M | $11.9M | $12.2M | $13.0M | $13.4M | $12.6M | $9.1M | $1.3M | $2.1M | ||||||||
| Deferred Revenue Current | $7.0K | $32.0K | $216.0K | $607.0K | $814.0K | $1.3M | $1.7M | $1.5M | $1.5M | $2.7M | $1.8M | $10.1M | $9.8M | ||||||||
| Income Tax Expense Benefit | $3.0K | $2.0K | $4.0K | $7.0K | $12.0K | $14.0K | $16.0K | $12.0K | $14.0K | ||||||||||||
| Impairment Of Long Lived Assets To Be Disposed Of | $0.00 | $0.00 | $0.00 | $1.9M | $1.6M | ||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $24.0K | -$29.0K | -$8.0K | $20.0K | -$15.0K | -$22.0K | ||||||||||||
| Restructuring Charges | -$21.0K | $398.0K | $885.0K | $2.8M | $6.5M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$10.7M | $11.6M | $89.4M | $80.8M | $34.3M | $74.5M | -$123.3M | -$107.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $17.9M | $42.6M | $23.7M | $33.9M | $46.1M | $74.9M | $10.1M | $24.2M |
| Retained Earnings Accumulated Deficit | -$433.7M | -$404.8M | -$311.4M | -$248.7M | -$193.4M | -$149.9M | -$127.8M | |
| Restricted Cash Noncurrent | $2.0M | $2.0M | $1.4M | $1.4M | $329.0K | $329.0K | $329.0K | |
| Property Plant And Equipment Net | $1.1M | $1.4M | $2.0M | $2.2M | $4.5M | $2.2M | $237.0K | |
| Prepaid Expense And Other Assets Current | $379.0K | $2.4M | $2.1M | $2.9M | $2.2M | $1.3M | $311.0K | |
| Operating Lease Right Of Use Asset | $16.8M | $19.9M | $33.2M | $2.2M | $1.4M | $2.3M | $3.2M | |
| Operating Lease Liability Current | $4.8M | $4.1M | $5.4M | $1.5M | $1.1M | $985.0K | $899.0K | |
| Liabilities Current | $9.5M | $12.6M | $19.6M | $14.5M | $18.2M | $4.9M | $5.2M | |
| Liabilities And Stockholders Equity | $36.1M | $66.3M | $142.6M | $110.0M | $54.9M | $80.8M | $15.0M | |
| Liabilities | $46.8M | $54.8M | $53.2M | $29.2M | $20.6M | $6.3M | $7.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$24.7M | $18.8M | -$10.2M | -$12.1M | -$28.8M | $64.8M | -$14.1M | |
| Cash And Cash Equivalents At Carrying Value | $15.9M | $40.6M | $22.4M | $32.6M | $45.7M | $74.6M | $9.8M | |
| Assets Current | $16.3M | $43.0M | $104.8M | $100.8M | $47.9M | $75.9M | $10.1M | |
| Assets | $36.1M | $66.3M | $142.6M | $110.0M | $54.9M | $80.8M | $15.0M | |
| Additional Paid In Capital Common Stock | $423.0M | $416.4M | $400.7M | $329.4M | $227.7M | $224.4M | $4.4M | |
| Accounts Payable Current | $663.0K | $1.2M | $3.1M | $2.6M | $3.1M | $922.0K | $1.1M | |
| Operating Lease Liability Noncurrent | $25.4M | $30.3M | $21.4M | $667.0K | $379.0K | $1.5M | $2.4M | |
| Accrued Expenses And Other Liabilities Current | $9.0M | $4.3M | $3.0M | $3.2M | ||||
| Common Stock Value | $2.0K | $1.0K | $57.0K | $32.0K | $13.0K | $13.0K | ||
| Other Assets Noncurrent | $0.00 | $1.1M | $3.3M | $762.0K | $118.0K | $1.1M | ||
| Deferred Offering Costs Incurred But Not Yet Paid | $2.0K | $870.0K | ||||||
| Available For Sale Debt Securities Gross Unrealized Loss | $33.0K | |||||||
| Stock Issued During Period Value Issuance Of Common Stock And Pre Funded Warrants Net Of Issuance Costs | $4.3M | $10.0K | $46.5M | $96.3M | ||||
| Short Term Investments | $0.00 | $80.4M | $65.3M | $0.00 | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $13.7M | $18.2M | $13.0K | $4.0M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.3M | $3.5M | $492.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $33.0K | $10.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.3M | $1.6M | $3.9M | $20.6M | $31.0M | $77.5M | $84.2M | $98.6M | $66.1M | $93.2M | $106.2M | $23.3M | $47.2M | $57.5M | $67.6M | $80.9M | $86.8M | -$126.8M | -$119.0M | -$114.8M | -$110.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $24.0M | $31.8M | $33.7M | $25.8M | $33.9M | $17.8M | $26.2M | $55.8M | $23.4M | $111.0M | $122.1M | $34.1M | $58.5M | $69.4M | $66.4M | $81.9M | $86.9M | $35.6M | $14.3M | $18.2M | $21.2M | ||
| Retained Earnings Accumulated Deficit | -$426.8M | -$420.8M | -$413.3M | -$393.8M | -$381.9M | -$333.8M | -$296.2M | -$280.5M | -$264.9M | -$234.4M | -$214.9M | -$200.4M | -$179.8M | -$168.7M | -$157.7M | -$142.9M | -$136.5M | -$132.0M | |||||
| Restricted Cash Noncurrent | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $1.4M | $1.1M | $1.4M | $1.1M | $1.1M | $329.0K | $329.0K | $329.0K | $329.0K | $329.0K | $329.0K | $329.0K | |||||
| Property Plant And Equipment Net | $1.1M | $1.2M | $1.3M | $1.6M | $1.7M | $3.8M | $726.0K | $560.0K | $2.0M | $3.8M | $4.0M | $4.3M | $4.7M | $3.9M | $3.2M | $917.0K | $329.0K | $284.0K | |||||
| Prepaid Expense And Other Assets Current | $964.0K | $1.3M | $2.2M | $2.8M | $1.9M | $2.3M | $2.4M | $1.8M | $2.1M | $2.3M | $1.4M | $1.8M | $2.8M | $1.0M | $1.2M | $2.0M | $2.7M | $293.0K | |||||
| Operating Lease Right Of Use Asset | $17.6M | $18.4M | $19.1M | $20.7M | $21.5M | $45.6M | $6.1M | $1.4M | $1.8M | $608.0K | $860.0K | $1.1M | $1.6M | $1.8M | $2.1M | $2.5M | $2.8M | $3.0M | |||||
| Operating Lease Liability Current | $4.7M | $4.6M | $4.2M | $4.0M | $4.3M | $4.5M | $1.4M | $1.7M | $1.9M | $654.0K | $926.0K | $1.1M | $1.1M | $1.0M | $1.0M | $964.0K | $943.0K | $919.0K | |||||
| Liabilities Current | $9.5M | $11.2M | $11.5M | $15.0M | $19.3M | $18.7M | $19.2M | $14.1M | $14.2M | $13.6M | $9.9M | $17.8M | $17.8M | $5.9M | $4.2M | $4.7M | $3.9M | $5.2M | |||||
| Liabilities And Stockholders Equity | $43.7M | $52.6M | $56.3M | $78.8M | $94.6M | $141.5M | $120.6M | $125.7M | $93.9M | $119.5M | $130.0M | $47.3M | $67.8M | $76.3M | $72.9M | $87.3M | $92.7M | $40.8M | |||||
| Liabilities | $48.0M | $51.0M | $52.4M | $58.1M | $63.6M | $64.0M | $36.3M | $27.1M | $27.8M | $26.2M | $19.0M | $19.2M | $20.6M | $18.8M | $5.4M | $6.4M | $5.9M | $7.4M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$8.8M | -$6.0M | -$10.5M | -$12.0M | -$8.5M | $25.4M | -$3.1M | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $22.1M | $29.8M | $31.7M | $23.8M | $31.9M | $15.8M | $24.9M | $54.4M | $22.0M | $109.6M | $120.7M | $33.8M | $58.1M | $69.0M | $66.1M | $81.6M | $86.6M | $35.2M | |||||
| Assets Current | $23.0M | $31.1M | $33.9M | $54.4M | $69.4M | $89.4M | $104.9M | $118.3M | $84.8M | $112.2M | $122.4M | $40.6M | $60.9M | $70.1M | $67.4M | $83.6M | $89.3M | $35.5M | |||||
| Assets | $43.7M | $52.6M | $56.3M | $78.8M | $94.6M | $141.5M | $120.6M | $125.7M | $93.9M | $119.5M | $130.0M | $47.3M | $67.8M | $76.3M | $72.9M | $87.3M | $92.7M | $40.8M | |||||
| Additional Paid In Capital Common Stock | $422.4M | $422.4M | $417.1M | $414.3M | $412.9M | $411.2M | $380.4M | $379.1M | $331.0M | $327.6M | $325.9M | $228.6M | $227.0M | $226.2M | $225.2M | $223.8M | $223.3M | $5.2M | |||||
| Accounts Payable Current | $627.0K | $680.0K | $725.0K | $2.3M | $5.0M | $2.8M | $5.1M | $4.2M | $4.0M | $2.9M | $1.7M | $2.4M | $2.9M | $1.9M | $1.2M | $530.0K | $1.1M | $1.4M | |||||
| Operating Lease Liability Noncurrent | $26.7M | $27.9M | $29.1M | $31.3M | $32.5M | $33.4M | $4.9M | $191.0K | $3.0K | $3.0K | $99.0K | $656.0K | $929.0K | $1.2M | $1.7M | $2.0M | $2.2M | ||||||
| Accrued Expenses And Other Liabilities Current | $1.1M | $2.4M | $2.2M | $2.6M | $3.2M | $6.1M | $10.1M | $9.4M | $11.1M | $6.7M | $6.8M | $7.3M | $5.5M | $4.2M | $4.0M | $3.0M | $2.0M | $3.2M | $1.9M | $2.9M | |||
| Common Stock Value | $2.0K | $2.0K | $66.0K | $65.0K | $65.0K | $61.0K | $50.0K | $50.0K | $32.0K | $32.0K | $32.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | ||||||
| Other Assets Noncurrent | $683.0K | $7.5M | $4.4M | $3.8M | $1.8M | $1.7M | $1.1M | ||||||||||||||||
| Deferred Offering Costs Incurred But Not Yet Paid | $121.0K | $68.0K | $702.0K | ||||||||||||||||||||
| Available For Sale Debt Securities Gross Unrealized Loss | $29.0K | $8.0K | $15.0K | $22.0K | |||||||||||||||||||
| Stock Issued During Period Value Issuance Of Common Stock And Pre Funded Warrants Net Of Issuance Costs | $4.3M | $46.7M | $96.3M | ||||||||||||||||||||
| Short Term Investments | $27.8M | $35.6M | $71.3M | $77.7M | $61.8M | $60.7M | |||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $13.7M | $4.0M | |||||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $933.0K | $726.0K | |||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $20.0K | -$4.0K | $25.0K | -$7.0K | -$27.0K | -$12.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.3M | $6.7M | $5.9M | $5.4M | $2.8M | $1.8M | $244.0K |
| Net Cash Provided By Used In Operating Activities | -$28.9M | -$70.0M | -$63.3M | -$43.4M | -$25.8M | -$21.1M | -$13.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.1M | $380.0K | -$867.0K | $764.0K | $847.0K | $1.0M | -$561.0K |
| Increase Decrease In Operating Lease Right Of Use Asset | -$3.1M | -$1.4M | $5.1M | $868.0K | -$946.0K | -$894.0K | -$864.0K |
| Increase Decrease In Operating Lease Liability | -$4.1M | -$3.4M | -$1.2M | $763.0K | -$986.0K | -$900.0K | -$840.0K |
| Increase Decrease In Accounts Payable | -$516.0K | -$1.9M | $450.0K | -$2.4M | $2.4M | $345.0K | -$205.0K |
| Payments To Acquire Property Plant And Equipment | $116.0K | $2.3M | $1.0M | $164.0K | $3.4M | $1.8M | $211.0K |
| Net Cash Provided By Used In Investing Activities | -$98.0K | $80.3M | -$12.6M | -$65.0M | -$3.4M | -$1.8M | -$211.0K |
| Net Cash Provided By Used In Financing Activities | $4.3M | $8.5M | $65.7M | $96.3M | $359.0K | $87.7M | -$115.0K |
| Proceeds From Stock Options Exercised | $3.0K | $103.0K | $8.0K | $604.0K | $8.0K | $111.0K | |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $1.5M | $4.8M | $1.2M | -$87.0K | $1.7M | ||
| Payments Of Stock Issuance Costs | $726.0K | $290.0K | $3.7M | $4.2M | $245.0K | ||
| Increase Decrease In Contract With Customer Liability | -$398.0K | -$1.5M | -$1.6M | $3.6M | $11.7M | ||
| Increase Decrease In Other Current Assets | -$1.1M | -$210.0K | $574.0K | $500.0K | $118.0K | ||
| Payments To Acquire Investments | $47.9M | $122.4M | $64.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $825.0K | $2.2M | $1.6M | $844.0K | $599.0K | $134.0K | $48.0K |
| Net Cash Provided By Used In Operating Activities | -$8.8M | -$22.5M | -$15.9M | -$11.9M | -$7.6M | -$4.0M | -$3.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$278.0K | $257.0K | -$843.0K | -$371.0K | -$78.0K | -$18.0K | -$35.0K |
| Increase Decrease In Operating Lease Right Of Use Asset | -$782.0K | $824.0K | -$398.0K | -$246.0K | -$232.0K | -$219.0K | -$226.0K |
| Increase Decrease In Operating Lease Liability | -$1.0M | -$590.0K | -$125.0K | -$257.0K | -$236.0K | -$215.0K | -$214.0K |
| Increase Decrease In Accounts Payable | -$454.0K | -$560.0K | $3.3M | -$663.0K | $452.0K | $432.0K | -$46.0K |
| Payments To Acquire Property Plant And Equipment | $2.1M | $45.0K | $93.0K | $1.2M | $8.0K | $52.0K | |
| Net Cash Provided By Used In Investing Activities | $7.9M | $5.3M | -$93.0K | -$1.2M | -$8.0K | -$52.0K | |
| Net Cash Provided By Used In Financing Activities | $8.6M | $4.0K | $6.0K | $262.0K | $29.5M | ||
| Proceeds From Stock Options Exercised | $3.0K | $4.0K | $8.0K | $262.0K | |||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $827.0K | -$2.3M | -$87.0K | -$983.0K | -$381.0K | $527.0K | |
| Payments Of Stock Issuance Costs | $169.0K | $2.0K | $773.0K | ||||
| Increase Decrease In Contract With Customer Liability | -$183.0K | -$532.0K | -$410.0K | $4.5M | |||
| Increase Decrease In Other Current Assets | -$568.0K | $2.4M | $260.0K | ||||
| Payments To Acquire Investments | $20.5M | $4.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$18.62 | -$71.75 | -$1.26 | -$1.83 | -$3.35 | -$2.59 | -$82.23 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 275.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 1.8M | 1.3M | 57.2M | 31.8M | 13.0M | 12.9M | 230.9K |
| Common Stock Shares Issued | 1.8M | 1.3M | 57.2M | 31.8M | 13.0M | 12.9M | 230.9K |
| Weighted Average Number Of Shares Outstanding Basic | 1.6M | 1.3M | 49.8M | 30.2M | 13.0M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 1.6M | 1.3M | 49.8M | 30.2M | 13.0M | ||
| Earnings Per Share Basic | $-18.62 | $-71.75 | $-1.26 | $-1.83 | $-3.35 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.0M | 8.6M | 202.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.38 | -$5.51 | -$0.13 | -$9.07 | -$36.76 | -$0.35 | -$0.27 | -$0.36 | -$0.44 | -$0.40 | -$0.42 | -$0.92 | -$0.85 | -$0.85 | -$0.60 | -$0.49 | -$0.56 | -$18.70 | -$19.20 | -$23.04 | -$21.54 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 400.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 1.6M | 1.6M | 65.9M | 65.5M | 65.5M | 61.0M | 49.5M | 49.5M | 31.8M | 31.8M | 31.8M | 13.0M | 13.0M | 13.0M | 13.0M | 12.9M | 12.9M | 230.9K | |||
| Common Stock Shares Issued | 1.6M | 1.6M | 65.9M | 65.5M | 65.5M | 61.0M | 49.5M | 49.5M | 31.8M | 31.8M | 31.8M | 13.0M | 13.0M | 13.0M | 13.0M | 12.9M | 12.9M | 230.9K | |||
| Weighted Average Number Of Shares Outstanding Basic | 1.8M | 1.3M | 65.8M | 1.3M | 1.3M | 64.0M | 57.0M | 43.7M | 36.8M | 36.8M | 33.9M | 13.0M | 13.0M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.8M | 1.3M | 65.8M | 1.3M | 1.3M | 64.0M | 57.0M | 43.7M | 36.8M | 36.8M | 33.9M | 13.0M | 13.0M | ||||||||
| Earnings Per Share Basic | $-3.38 | $-5.51 | $-0.13 | $-9.07 | $-36.76 | $-0.35 | $-0.27 | $-0.36 | $-0.44 | $-0.40 | $-0.42 | $-0.92 | $-0.85 | ||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 33.9M | 13.0M | 13.0M | 13.0M | 12.9M | 12.9M | 8.2M | 230.9K | 220.9K | 185.7K | 170.2K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.3M | $7.0M | $5.6M | $5.4M | $2.7M | $1.8M | $244.0K |
| Investment Income Interest | $1.1M | $3.0M | $4.5M | $1.0M | $102.0K | $82.0K | $213.0K |
| Depreciation | $459.0K | $471.0K | $278.0K | $1.1M | $1.0M | $95.0K | $27.0K |
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $103.0K | $8.0K | $604.0K | $8.0K | $111.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $623.0K | $41.0K | $205.0K | $2.0K | |||
| Stock Issued During Period Shares Stock Options Exercised | 0.00 | 1.0K | 57.4K | 2.7K | 72.2K | 2.8K | |
| Stock Issued During Period Value New Issues | $4.9M | $19.1M | $57.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $34.0K | $914.0K | $825.0K | $1.5M | $1.6M | $1.9M | $1.4M | $1.4M | $1.6M | $1.7M | $1.1M | $844.0K | $733.0K | $656.0K | $599.0K | $468.0K | $619.0K | $134.0K | $49.0K | $44.0K | $48.0K |
| Investment Income Interest | $256.0K | $410.0K | $298.0K | $576.0K | $855.0K | $1.1M | $1.2M | $897.0K | $1.1M | $60.0K | $34.0K | $14.0K | $26.0K | $26.0K | $29.0K | $29.0K | $5.0K | $16.0K | $63.0K | $80.0K | $35.0K |
| Depreciation | $100.0K | $200.0K | $128.0K | $200.0K | $136.0K | $284.0K | $300.0K | $300.0K | $280.0K | $400.0K | $300.0K | $70.0K | $33.0K | $13.0K | $8.0K | $6.0K | $6.0K | $8.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $2.0K | $97.0K | $4.0K | $8.0K | $11.0K | $331.0K | $262.0K | $1.0K | $22.0K | $87.0K | ||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $350.0K | $49.0K | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 0.00 | 918.00 | 2.1K | 2.7K | 30.4K | 0.00 | |||||||||||||||
| Stock Issued During Period Value New Issues | $4.9M | -$44.0K | $57.3M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.